EDAP TMS SA to Announce Third Quarter 2020 Financial Results on November 18, 2020

Rhea-AI Summary

EDAP TMS SA (Nasdaq: EDAP), a leader in therapeutic ultrasound, will release its third-quarter financial results for 2020 after market close on November 18, 2020. A conference call, led by CEO Marc Oczachowski and CFO François Dietsch, is scheduled for November 19, 2020, at 8:30 AM EDT. This event will allow investors and stakeholders to discuss the results and future outlook. EDAP TMS is recognized for its minimally invasive ultrasound medical devices, including the Focal One® and ExactVu™ systems for prostate treatment.

Positive

• Upcoming conference call scheduled for post-Q3 earnings release, providing clarity on financial performance.

Negative

• None.

Company to host conference call and webcast on Thursday, November 19 at 8:30 am EDT

LYON, France, November 9, 2020 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the third quarter ended September 30, 2020 after the markets close on Wednesday, November 18, 2020.

An accompanying conference call and webcast will be conducted by Marc Oczachowski, Chairman of the Board and Chief Executive Officer, and François Dietsch, Chief Financial Officer. The call will be held at 8:30am EDT on Thursday, November 19, 2020. Please refer to the information below for conference call dial-in information and webcast registration.

Conference Call & Webcast
Thursday, November 19^th @ 8:30am Eastern Time
Domestic:                    877-451-6152
International:              201-389-0879
Passcode:                    13712293
Webcast:                     http://public.viavid.com/index.php?id=142115

About EDAP TMS SA

A recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer.  EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, and us.hifu-prostate.com.

CONTACTS:
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com

Investor Contact
Jeremy Feffer
LifeSci Advisors, LLC
212-915-2568
jeremy@lifesciadvisors.com

FAQ

When will EDAP TMS release its Q3 2020 earnings?

EDAP TMS will release its Q3 2020 earnings after the market closes on November 18, 2020.

What time is the EDAP TMS conference call scheduled?

The EDAP TMS conference call is scheduled for November 19, 2020, at 8:30 AM EDT.

Who will lead the EDAP TMS conference call?

The conference call will be led by CEO Marc Oczachowski and CFO François Dietsch.

How can I access the EDAP TMS earnings call?

You can access the EDAP TMS earnings call via conference call dial-in or the webcast registration link provided in their press release.